Literature DB >> 19960456

Safety assessment of botanicals and botanical preparations used as ingredients in food supplements: testing an European Food Safety Authority-tiered approach.

Gerrit Speijers1, Bernard Bottex, Birgit Dusemund, Andrea Lugasi, Jaroslav Tóth, Judith Amberg-Müller, Corrado L Galli, Vittorio Silano, Ivonne M C M Rietjens.   

Abstract

This article describes results obtained by testing the European Food Safety Authority-tiered guidance approach for safety assessment of botanicals and botanical preparations intended for use in food supplements. Main conclusions emerging are as follows. (i) Botanical ingredients must be identified by their scientific (binomial) name, in most cases down to the subspecies level or lower. (ii) Adequate characterization and description of the botanical parts and preparation methodology used is needed. Safety of a botanical ingredient cannot be assumed only relying on the long-term safe use of other preparations of the same botanical. (iii) Because of possible adulterations, misclassifications, replacements or falsifications, and restorations, establishment of adequate quality control is necessary. (iv) The strength of the evidence underlying concerns over a botanical ingredient should be included in the safety assessment. (v) The matrix effect should be taken into account in the safety assessment on a case-by-case basis. (vi) Adequate data and methods for appropriate exposure assessment are often missing. (vii) Safety regulations concerning toxic contaminants have to be complied with. The application of the guidance approach can result in the conclusion that safety can be presumed, that the botanical ingredient is of safety concern, or that further data are needed to assess safety.

Mesh:

Substances:

Year:  2010        PMID: 19960456     DOI: 10.1002/mnfr.200900240

Source DB:  PubMed          Journal:  Mol Nutr Food Res        ISSN: 1613-4125            Impact factor:   5.914


  4 in total

Review 1.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

2.  Preclinical Safety Assessment of Standardized Extract of Centella asiatica (L.) Urban Leaves.

Authors:  Pallavi O Deshpande; Vishwaraman Mohan; Prasad Thakurdesai
Journal:  Toxicol Int       Date:  2015 Jan-Apr

3.  Pro-Apoptotic Activity of Artichoke Leaf Extracts in Human HT-29 and RKO Colon Cancer Cells.

Authors:  Milena Villarini; Mattia Acito; Raffaella di Vito; Samuele Vannini; Luca Dominici; Cristina Fatigoni; Rita Pagiotti; Massimo Moretti
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

4.  LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus Merr.

Authors:  Eric R Secor; Steven M Szczepanek; Anurag Singh; Linda Guernsey; Prabitha Natarajan; Karim Rezaul; David K Han; Roger S Thrall; Lawrence K Silbart
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-02       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.